MERTK and neoplasm: Because MERTK is known to affect tumor-associated macrophage polarization by modulating efferocytosis8 and this study revealed that BMS794833 is a type II inhibitor that directly binds to MERTK, the blockade of conversion in that study may have been caused by MERTK inhibition.